Transcatheter heart valve therapies
Transcatheter heart valve therapies supports independent investigators and academic sponsors conducting studies of valve therapies to advance clinical knowledge and address meaningful care questions.
Funder: Edwards Lifesciences
Due Dates: Rolling (applications accepted throughout the year)
Funding Amounts: Financial or in-kind support; approved awards may be less than requested
Summary: Supports investigator-initiated research that advances clinical knowledge of transcatheter heart valve therapies.
Key Information: Studies must be developed and sponsored by an independent investigator or academic sponsor.
Description
Edwards Lifesciences considers unsolicited requests for investigator-initiated studies in heart valve science and hemodynamic monitoring. This research grant category focuses on transcatheter heart valve therapies, with areas of interest including M-TEER and TTVR. Its goal is to advance clinical knowledge through independent research that addresses meaningful scientific or clinical questions.
Current areas of focus include disease prevalence and progression, improving clinical outcomes, expanding patient populations and indications, and improving cost pathways. Edwards considers a study’s scientific and medical merit, its alignment with these areas, and the resources it requires.
